Gimv - News

03/03/2020 - 14:54 Portfolio

Alro is nominated trendsgazelle ambassador for medium sized companies

02/03/2020 - 07:30 Portfolio

Gimv invests in AME, specialised producer of smart electronics for tomorrow’s products, located in Eindhoven Brainport

20/02/2020 - 17:50 Portfolio

Gimv to enter partnership with Köberl Group to achieve further growth in the facility management and technical building services sector

18/02/2020 - 11:44 Portfolio

IMPACT and Haldu Groep guarantee continuity for employees, temporary workers and customers through the acquisition of a number of standalone activities of DeGraaf Groep

06/02/2020 - 18:24 Portfolio

JenaValve Technology Closes USD 50 Million Financing

23/01/2020 - 11:39 Portfolio

General Fusion Closes $65M of Series E Financing - Gimv contributes to the search of an answer for a carbon-free energy future

19/12/2019 - 09:22 Portfolio

Topas Therapeutics Announces First Patient Enrolled in Phase 1 Trial with TPM203 in Pemphigus Vulgaris

12/12/2019 - 09:00 Portfolio

Cegeka reinforces international position by acquiring KPN Consulting

04/12/2019 - 06:45 Portfolio

Imcheck Therapeutics raises USD 53 million, Gimv increases its investment in the immuno-oncology space

27/11/2019 - 10:27 Portfolio

Backed by Gimv, French Groupe Claire acquires Ijinus and reinforces its products pole for water systems equipment and solutions

21/11/2019 - 07:00 Financial

Further growth and continuing strong portfolio results

29/10/2019 - 15:43 Portfolio

GTX medical BV and NeuroRecovery Technologies Inc. Merge to Create Leading Neurostimulation Company for Spinal Cord Injury

14/10/2019 - 08:00 Portfolio

Eric de Montgolfier appointed as CEO of Invest Europe

09/09/2019 - 16:50 Portfolio

One of A Kind Technologies expands with KOAT to accelerate Agriculture growth strategy

09/09/2019 - 13:46 Portfolio

Equipe Zorgbedrijven intends to take over Heuvelrug Eye Clinic

05/09/2019 - 08:00 Portfolio

iSTAR Medical announces EUR 40.1 million financing round lead by Gimv to support further development of an innovative glaucoma treatment

30/07/2019 - 08:00 Portfolio

AgroSavfe raises EUR 35 million, Gimv invests additional resources for further development of biocontrols as a new standard for sustainable crop protection.

30/07/2019 - 07:45 Portfolio

Gimv sells stake in thinkstep AG, the Stuttgart-based specialist in sustainability software.

30/07/2019 - 07:30 Portfolio

Gimv exits Legallais, ironmongery distributor for building professionals in France.

25/07/2019 - 08:00 Portfolio

Gimv and other shareholders sell biopharmaceutical company Breath Therapeutics to Zambon after a fast development

26/06/2019 - 17:45 Financial

Report of the Annual General Shareholders’ Meeting - Approval of a gross dividend of EUR 2.50 per share

21/06/2019 - 17:45 Financial

Closure of the subscription periods for the bond issue for private and institutional investors for the total maximum amount of EUR 250 million

19/06/2019 - 07:30 Financial

Gimv NV launches a bond-issue for retail and institutional investors for a total nominal amount of at least EUR 150 million

18/06/2019 - 08:30 Portfolio

Gimv invests in Alro Group, renowned car and truck coating company

13/06/2019 - 10:43 Portfolio

Filter news:

Alro is nominated trendsgazelle ambassador for medium sized companies

Gimv invests in AME, specialised producer of smart electronics for tomorrow’s products, located in Eindhoven Brainport

Gimv to enter partnership with Köberl Group to achieve further growth in the facility management and technical building services sector

IMPACT and Haldu Groep guarantee continuity for employees, temporary workers and customers through the acquisition of a number of standalone activities of DeGraaf Groep

JenaValve Technology Closes USD 50 Million Financing

General Fusion Closes $65M of Series E Financing - Gimv contributes to the search of an answer for a carbon-free energy future

Topas Therapeutics Announces First Patient Enrolled in Phase 1 Trial with TPM203 in Pemphigus Vulgaris

Cegeka reinforces international position by acquiring KPN Consulting

Imcheck Therapeutics raises USD 53 million, Gimv increases its investment in the immuno-oncology space

Backed by Gimv, French Groupe Claire acquires Ijinus and reinforces its products pole for water systems equipment and solutions

Further growth and continuing strong portfolio results

GTX medical BV and NeuroRecovery Technologies Inc. Merge to Create Leading Neurostimulation Company for Spinal Cord Injury

Eric de Montgolfier appointed as CEO of Invest Europe

One of A Kind Technologies expands with KOAT to accelerate Agriculture growth strategy

Equipe Zorgbedrijven intends to take over Heuvelrug Eye Clinic

iSTAR Medical announces EUR 40.1 million financing round lead by Gimv to support further development of an innovative glaucoma treatment

AgroSavfe raises EUR 35 million, Gimv invests additional resources for further development of biocontrols as a new standard for sustainable crop protection.

Gimv sells stake in thinkstep AG, the Stuttgart-based specialist in sustainability software.

Gimv exits Legallais, ironmongery distributor for building professionals in France.

Gimv and other shareholders sell biopharmaceutical company Breath Therapeutics to Zambon after a fast development

Report of the Annual General Shareholders’ Meeting - Approval of a gross dividend of EUR 2.50 per share

Closure of the subscription periods for the bond issue for private and institutional investors for the total maximum amount of EUR 250 million

Gimv NV launches a bond-issue for retail and institutional investors for a total nominal amount of at least EUR 150 million

Gimv invests in Alro Group, renowned car and truck coating company

IMPACT obtains majority interest in Dutch specialized technical staffing agency Haldu Groep